The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.
about
Synaptophysin: A novel marker for human and rat hepatic stellate cellsPrimary biliary cirrhosis: From bench to bedsideEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsPortal hypertension correlates with splenic stiffness as measured with MR elastographyEndothelin-1 suppresses plasma membrane Ca++-ATPase, concomitant with contraction of hepatic sinusoidal endothelial fenestraeImportant role for endothelins in acute hepatic ischemia/reperfusion injury.Portal flow augmentation for liver cirrhosis.Liver fibrosis.Tetrandrine stimulates the apoptosis of hepatic stellate cells and ameliorates development of fibrosis in a thioacetamide rat model.Liver fibrosis: an intravoxel incoherent motion (IVIM) study.Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.Infection, coagulation, and variceal bleeding in cirrhosis.Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver.Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 ExpressionExpression of local renin and angiotensinogen mRNA in cirrhotic portal hypertensive patient.New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varicesHeat shock protein 90 is responsible for hyperdynamic circulation in portal hypertensive rats.Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis.Experimental models of liver fibrosisOxidative and nitrosative stress and fibrogenic response.Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertensionAttenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats.Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.Current concepts on the role of nitric oxide in portal hypertension.Pathophysiology of portal hypertension and its clinical links.Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats.Murine study of portal hypertension associated endothelin-1 hypo-responseDefects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation.Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension.In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.Endothelin-1 derived from spleen-activated Rho-kinase pathway in rats with secondary biliary cirrhosis.Changes in inward rectifier K+ channels in hepatic stellate cells during primary culture.Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.Cardiopulmonary complications in chronic liver disease.Pathogenesis of primary biliary cirrhosis: a unifying model.Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
P2860
Q24670497-33ECA288-5010-4A48-8497-BA14A571292CQ26799419-11F13BFA-D465-4F28-AB5B-2BBE2690DF36Q27023122-D6E55D88-E776-4C3E-A3A3-53CB6D55F5CFQ28303698-1FDB4E11-D5EF-47DD-9CC8-E4CA225640FFQ30466193-12040FAD-42C9-406D-B5E7-0E2C10353B25Q30883488-D2B8CBEB-F5BD-401A-A0E3-709CDA7047C1Q30985778-75F8BCE1-841A-4583-98F5-1617F6044BE0Q33994403-1C452581-5923-42B0-8030-991B03C934FCQ34005628-F0D88221-894C-4AA0-A165-01C5AE0986FEQ34099536-BA08CEBD-8BE5-4730-80A4-134C3817BDACQ34159097-5A5B88D4-FBB1-4358-9BB4-8CD3FCAF6C8BQ34309152-723D178F-46A4-4E36-8338-013799319969Q34400962-C5B55B93-167D-4311-B838-75B05535D4FCQ34779763-776BA742-9922-4D9D-B1CD-B679345DF512Q35165731-0A4D6BAE-F0AF-4A25-914B-2375FE9F5551Q35355267-B416334D-9FAD-43D3-A2D8-8D74DF637C02Q36095032-34167CD0-FE97-45F0-ACF2-E75A3B5C162CQ36190762-DF604CF3-9E48-4D08-9B9C-9A6C0187D5EBQ36193124-9C74DD38-512C-4A4B-ABAF-01267E5A803DQ36308872-3337E00E-8DFB-4AAB-A78B-1E2618FA73ACQ36339714-527C738C-D257-440C-B7DB-0CAB89396E11Q36442525-589D5713-DCEE-496C-9208-A915351870E9Q37037061-D2EB1000-8093-4615-B6F7-C4F3787F1DDEQ37174141-ED92910E-326D-4A6E-9A13-5C80FF2B234EQ37176235-0AEFE62E-F4C9-4090-826C-3A8D2A86CC51Q37387576-78DA72D7-9F85-40A3-80E7-0EBFEE633A2FQ38006726-31061D8B-369E-4952-85FB-4958ADA654FDQ38095931-C48F5C8F-A7F5-43E8-961B-DC16AA5BD690Q38371453-C19CF005-6298-4A73-9FC2-4C08B85F7525Q38905396-58CEEF28-DB47-4EB0-B882-D0A1005A16B1Q39923460-6CEEC7EE-4C22-4C9D-986A-2B21764FB573Q40354874-58E858A0-73DC-4CFF-8582-A3F583DE9015Q41508038-933C0CEB-B39C-43E5-BA26-6196F7133CE3Q41925225-1A4AB5D1-F7F7-4FEF-ADD4-B2F73C33B5F9Q41975697-0D868534-1504-4845-92F9-FEAC64C61E20Q42056064-A74E8E75-B9A2-4852-8815-B7BE6462FAF8Q42667685-44C87E8E-17F7-44B3-9C35-403D32D7ADC3Q42704576-9AA7BB44-76F7-43E5-807A-1C1B893E2447Q42726334-8069AC2F-C60C-4380-A6E2-8077C57B37DBQ45921438-A0C4FDA1-FE7E-4D43-A57F-210A297EA6DD
P2860
The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@ast
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@en
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@nl
type
label
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@ast
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@en
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@nl
prefLabel
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@ast
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@en
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@nl
P356
P1433
P1476
The cellular pathogenesis of p ...... endothelin, and nitric oxide.
@en
P2093
P356
10.1002/HEP.510250102
P407
P577
1997-01-01T00:00:00Z